| 2024 | Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study | CLINICAL CANCER RESEARCH |
| 2024 | Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
| NATURE COMMUNICATIONS |
| 2023 | Sustained deep partial response with axitinib and pembrolizumab in a patient with alveolar soft-part sarcoma: A case report and review of the literature | PEDIATRIC BLOOD & CANCER |
| 2023 | Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response
| CANCER RESEARCH AND TREATMENT |
| 2022 | Therapeutic Implications of TGF-β Pathway in Desmoid Tumor Based on Comprehensive Molecular Profiling and Clinicopathological Properties
| CANCERS |
| 2022 | Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study
| CANCER RESEARCH AND TREATMENT |
| 2022 | Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma | CLINICAL CANCER RESEARCH |
| 2021 | Prognostic implications of PD-L1 expression in patients with angiosarcoma
| FUTURE SCIENCE OA |
| 2021 | PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
| BMC CANCER |
| 2020 | Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA | ONCOLOGY |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
| 2018 | Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images | JOURNAL OF ORTHOPAEDIC SCIENCE |
| 2018 | Optimal radiotherapy strategy for primary or recurrent fibromatosis and long-term results
| PLOS ONE |
| 2017 | Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma | JOURNAL OF SURGICAL ONCOLOGY |
| 2017 | Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma
| CANCER MEDICINE |
| 2016 | Time to Surgery and Injury Severity Score
| Journal of Trauma and Injury |
| 2015 | Secondary malignant neoplasms after osteosarcoma: early onset and cumulative alkylating agent dose dependency | ANNALS OF SURGICAL ONCOLOGY |
| 2014 | Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma
| BMC CANCER |
| 2013 | 천골 및 골반골에 발생한 거대세포종에 대한 동맥 색전술 치료의 효용성 분석(Analysis for Usefulness of Arterial Embolization on Sacral and Pelvic Giant Cell Tumors)
| Journal of the Korean Bone and Joint Tumor Society (대한골관절종양학회지) |
| 2013 | Prognostic Factor Analysis in Patients with Metastatic Spine Disease Depending on Surgery and Conservative Treatment: Review of 577 Cases | ANNALS OF SURGICAL ONCOLOGY |
| 2012 | 연부 조직 육종에 대한 무계획적 절제술: 환자의 임상적 특징 및 치료 결과
| Journal of the Korean Bone and Joint Tumor Society (대한골관절종양학회지) |
| 2012 | Arthroscopic partial repair of irreparable large to massive rotator cuff tears | ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY |
http://orcid.org/0000-0002-3878-1944
(57188714319)
